Growth Metrics

Healthy Extracts (HYEX) Cash from Financing Activities (2016 - 2025)

Healthy Extracts filings provide 11 years of Cash from Financing Activities readings, the most recent being -$486274.0 for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities fell 1506.99% to -$486274.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$186906.0, a 1.31% increase, with the full-year FY2025 number at -$186906.0, up 1.31% from a year prior.
  • Cash from Financing Activities hit -$486274.0 in Q4 2025 for Healthy Extracts, down from $268829.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $846880.0 in Q1 2021 to a low of -$486274.0 in Q4 2025.
  • Median Cash from Financing Activities over the past 5 years was $35458.5 (2023), compared with a mean of $69648.0.
  • Biggest five-year swings in Cash from Financing Activities: soared 3755.28% in 2023 and later crashed 1506.99% in 2025.
  • Healthy Extracts' Cash from Financing Activities stood at $77199.0 in 2021, then surged by 79.7% to $138730.0 in 2022, then plummeted by 159.52% to -$82574.0 in 2023, then surged by 63.35% to -$30260.0 in 2024, then crashed by 1506.99% to -$486274.0 in 2025.
  • The last three reported values for Cash from Financing Activities were -$486274.0 (Q4 2025), $268829.0 (Q3 2025), and $83782.0 (Q2 2025) per Business Quant data.